American Red Cross to participate in Cerus' IDE study to address chikungunya and dengue
Cerus announced the American Red Cross will participate in Cerus’ clinical protocol to make the INTERCEPT Blood System for platelets available under an Expanded Access Investigational Device Exemption to regions in the United States with outbreaks of chikungunya and dengue virus. October 23, 2014